evaluation of OCTA following antiVEGF in patient having retinal disease non resolving central serous chorioretinopathy
- Conditions
- Health Condition 1: H32- Chorioretinal disorders in diseases classified elsewhere
- Registration Number
- CTRI/2024/08/072312
- Lead Sponsor
- Maulana Azad Medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1)Treatment naïve subjects in the age group of 25-50 years having non resolving central serous chrioretinopathy of more than four months duration along with subretinal fluid (SRF) involving fovea on optical coherence topography (oct) and active angiographic leakage of fundus fluorescein angiography (FFA)
2)Subject having best corrected visual acuity (BCVA) of at least 6/60
1)patients having ocular conditions causing accumulation of sub-retinal fluid like diabetic retinopathy,retinal vascular occlusion,ocular inflammation or ocular conditions causing macular exudation such as pathological myopia and antioxidants streaks
2)patients who have undergone any intraocular surgery other than uncomplicated cataract extraction
3)Risk of thrombo-emboli events and/or occurrence within past 6 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method